GWPH Greenwich Pharma is using Cannabis for this Lennox Gastaut Syndrome.

This company is about to launch and AMAZING ‘treatment’ called Epidiolex for Lennox-Gastaut syndrome, a rare, severe and difficult to treat form of childhood onset epilepsy.  These children and their families are suffering thru up to 200 seizures a day.  By dropping a couple of the Epidiolex drops into their mouth they are seeing amazing results.

Guess what – thee amazing treatment is derived from Cannabis. Period.

I am looking for a risk controlled entry for a long term buy and hold.  The company is doing amazing things spinning out over 150 different chemical properties of this amazing plant based medicine.

No, we don’t have a bunch of kids baked while watching their Ipads … this is a natural based science relief …

Right now, we’ve completed some pretty hefty patterns so I’m looking for any pullback to BUY.  Would really like to get this back to the ‘old breakout level’ for a BUY … note the MONSTER GAP on a monthly.

Pharma can be very wild based on FDA approval and Adverse Events and blah blah … but believe this company is onto something and the future is very bright.

Bart

Author: BART

BART is a CMT and an expert a "advanced" pattern recognition used w/in the intermarket analysis discipline. He's also an accomplished Business Development Executive providing solutions to a myriad of business markets.

Leave a Reply

Discover more from Bart's Charts

Subscribe now to keep reading and get access to the full archive.

Continue reading